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Mutant screens and transcriptome studies led us to consider whether the metabolism of glucose polymers,
i.e., maltose, maltodextrin, and glycogen, is important for Escherichia coli colonization of the intestine. By using
the streptomycin-treated mouse model, we found that catabolism of the disaccharide maltose provides a
competitive advantage in vivo to pathogenic E. coli O157:H7 and commensal E. coli K-12, whereas degradation
of exogenous forms of the more complex glucose polymer, maltodextrin, does not. The endogenous glucose
polymer, glycogen, appears to play an important role in colonization, since mutants that are unable to
synthesize or degrade glycogen have significant colonization defects. In support of the hypothesis that E. coli
relies on internal carbon stores to maintain colonization during periods of famine, we found that by providing
a constant supply of a readily metabolized sugar, i.e., gluconate, in the animal’s drinking water, the competitive
disadvantage of E. coli glycogen metabolism mutants is rescued. The results suggest that glycogen storage may
be widespread in enteric bacteria because it is necessary for maintaining rapid growth in the intestine, where
there is intense competition for resources and occasional famine. An important implication of this study is that
the sugars used by E. coli are present in limited quantities in the intestine, making endogenous carbon stores
valuable. Thus, there may be merit to combating enteric infections by using probiotics or prebiotics to
manipulate the intestinal microbiota in such a way as to limit the availability of sugars preferred by E. coli
O157:H7 and perhaps other pathogens.
In nature, the nutrients that support bacterial growth are rarely
available continuously and are almost always present in limiting
amounts, leading to the idea that bacterial existence is one of feast
or famine (24). Others have proposed the existence of an in-
between state, namely hunger, which is defined by expression of
carbon-scavenging systems (18). In the mammalian gastrointesti-
nal tract (9), despite growing in a mucus layer rich in carbohy-
drates, lipids, and proteins (27), Escherichia coli apparently leads
a scavenging lifestyle, using up to seven different sugars to support
its colonization (7, 16). It is likely that the availability of one or
more of its preferred nutrients in the intestine is limited and
variable. Thus, for E. coli to cope with life in a nutrient-limiting
environment where it is hungry or occasionally starving, we hy-
pothesize that successful competition and persistence in the in-
testine requires intracellular energy stores. Glycogen is the pri-
mary carbon and energy storage molecule for enteric bacteria,
including E. coli (5).
The discovery of glycogen in E. coli is credited to Cedergren
and Holme (6). In an early review of bacterial cell composition,
it was Neidhardt who first suggested that glycogen degradation
might be linked to energy metabolism (34). It is now well
established that glycogen is the fundamental carbon and en-
ergy storage compound for many bacteria and plays a major
role in long-term survival of the cell. Glycogen is synthesized
during times when carbon is abundant but other nutrients are
limiting (36). GlgA, glycogen synthase, is responsible for the
transfer of the glucosyl unit from ADP-glucose to the growing
glycogen polymer to form a new -1,4-glucosidic linkage (37).
GlgB is the branching enzyme that catalyzes formation of
-1,6-glucosidic linkages. GlgC, glucose-1-phosphate adenylyl-
transferase, forms ADP-glucose from glucose-1-phosphate and
ATP. GlgS is required for glycogen synthesis, its overproduc-
tion stimulates glycogen synthesis, and it is induced upon entry
into stationary in an RpoS-dependent manner (21). However,
GlgS has no defined role in glycogen synthesis, although its
crystal structure suggests involvement in protein-protein inter-
actions (25). Glycogen degradation occurs when carbon
sources become limiting (13). GlgP, glycogen phosphorylase,
catalyzes glycogen breakdown by removing glucose units from
the polysaccharide. GlgX, glycogen debranching enzyme, hy-
drolyzes -1,6-glucosidic linkages in limit dextrins generated by
GlgP (12).
In salmonellae, the role of glycogen metabolism in coloni-
zation and virulence is controversial, with one study suggesting
a connection between glycogen storage and virulence (4) and
another showing a minor role, at best (30). The contributions
of glycogen synthesis and degradation to animal colonization
have not been tested for E. coli. In support of the hypothesis
that glycogen metabolism is important for colonization, we
previously found that one of the genes involved in glycogen
metabolism, glgS, is highly induced in E. coli MG1655 when
growing on mucus, conditions that are thought to mimic nu-
trient availability in the intestine (7).
Since glycogen breakdown involves maltose and maltodextrins
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as intermediates, we also thought to examine whether catabolism
of exogenous maltose and maltodextrins supports colonization.
This possibility seemed reasonable since maltose metabolism
genes are also induced in E. coliMG1655 when growing on mucus
(7). Maltose consists of two glucose molecules joined by an -1,4
linkage; maltodextrins are longer glucose polymers. These sugars
are most commonly derived from starch and glycogen. At least
nine genes encode proteins that are involved in the utilization of
maltose and maltodextrins in E. coli (29). The maltose-inducible
porin for maltodextrin transport into the periplasm is encoded by
lamB (46). The maltose/maltodextrin transporter is a high-affinity
ABC system consisting of a periplasmic maltose-binding protein,
encoded by malE, and a transport complex encoded by malF,
malG, and malK (5). malQ (amylomaltase) and malP (maltodex-
trin phosphorylase) encode enzymes for maltose and maltodex-
trin catabolism, respectively. MalQ uses maltodextrins as maltose
acceptors in a reaction that releases glucose, which enters glyco-
lysis after being phosphorylated by glucokinase (5). MalP cleaves
glucosyl residues from the nonreducing end of maltodextrins,
forming -glucose-1-phosphate, which enters glycolysis after con-
version to glucose 6-phosphate by phosphoglucomutase (5). Mu-
tants lacking MalQ cannot grow on maltose, whereas malP
mutants can grow on maltose but not on maltodextrins (14).
We previously identified several monosaccharides utilized dur-
ing colonization of the mouse intestine by pathogenic E. coli
EDL933 (16) and commensal E. coli MG1655 (7). Here, we
explore the possibility that complex sugars, i.e., maltose, malto-
dextrin, and glycogen, support intestinal colonization. The results
demonstrate that maltose, but not maltodextrin, is important for
colonization of both pathogenic and commensal E. coli strains. In
addition, glycogen synthesis and glycogen degradation are impor-
tant for efficient intestinal colonization, suggesting a hunger or
famine lifestyle for E. coli in the mouse intestine. The results
increase our understanding of nutrient utilization in vivo and
provide new insights into host-pathogen interactions.
MATERIALS AND METHODS
Bacterial strains. The bacterial strains used in the present study were derived
from E. coli MG1655 Strr (streptomycin resistant), a K-12 strain (32), and E. coli
EDL933 Strr, a streptomycin-resistant derivative of the prototypical O157:H7
strain (31). The bacterial strains and plasmids used in the present study are listed
in Table 1.
Mutant constructions. Null alleles were constructed by using the allelic re-
placement method of Datsenko and Wanner (11), as described previously (7, 16),
such that target genes were deleted and replaced with kanamycin or chloram-
phenicol resistance cassettes, which served as selectable markers in mouse col-
onization assays, as described below. The null allele strains are identified in the
text by the genes that were deleted; single gene deletions began with the start
codon and ended with the stop codon, and consecutive gene deletions began with
the start codon of the first gene deleted and ended with the stop codon of the last
gene deleted. Strains containing multiple mutations were constructed by sequen-
tial allelic replacement; the first inserted cassette was removed with FLP recom-
binase (11), followed by subsequent allelic replacement(s) and removal of the
insertion as necessary, leaving the selectable marker in the last mutation made.
Mutant strains were verified by phenotype analysis and DNA sequencing.
Phenotypic analysis. To test for the ability to use sole carbon and energy
sources, mutants were grown overnight in MOPS [3-(N-morpholino) propane-
sulfonic acid] defined medium (35) containing 0.2% maltose or maltodextrin
(maltopentaose to maltoheptaose). Maltose and maltodextrin sensitivity were
evaluated by growth on Luria broth containing 0.2% carbohydrate. Cell growth
was monitored spectrophotometrically at 600 nm (OD600). To test for the ability
to synthesize glycogen, strains were grown overnight on Luria plates containing
2% glucose and stained with iodine vapor (14). In addition, the mutants used in
the present study were phenotyped for carbon source oxidation by using Biolog
GN2 (carbon nutrition) plates according to the manufacturer’s instructions.
Briefly, the mutants were grown overnight on tryptic soy agar, washed in Biolog
inoculating fluid (gellan gum, 0.2 g/liter; NaCl, 4.0 g/liter; Pluronic F-68, 0.3
g/liter; 2.5 mM thioglycolate), and the plates were inoculated with 150 ml per
well of a cell suspension with an OD600 of 0.2 to 0.3. The cells were incubated in
Biolog plates for 24 h at 37°C in an Omnilog system, and the amount of reduced
tetrazolium violet dye in each well was quantified every 15 min. The amount of
dye reduced corresponds to the extent of carbon source oxidized. Dye reduction
was plotted versus time, and the area under each resulting kinetic curve was used
as an overall measure of the cells’ ability to utilize each carbon source.
Mouse colonization experiments. The streptomycin-treated mouse model has
been used extensively to study colonization of the mouse large intestine by E. coli
and Salmonella enterica serovar Typhimurium (8, 9, 27). Briefly, three 6-week-old
CD-1 male mice were given drinking water containing streptomycin sulfate (5
g/liter) for 24 h to selectively remove the existing resident facultative microbiota
and then starved for food and water for 18 to 24 h. Unless otherwise indicated,
the mice were then fed approximately 105 CFU of both wild-type and mutant
strains in 1 ml of 20% sucrose. The wild-type strains were streptomycin resistant
TABLE 1. Strains and plasmids used in this studya
Strain or plasmida Genotypeb Source orreference
Strains
MG1655 Wild-type (CGSC 7740) CGSCc
MG1655 Strr Spontaneous Strr 32
MG1655 Strr Nalr Spontaneous Nalr 32
EDL933 Wild-type O157:H7 Alison O’Brien
EDL933 Strr Spontaneous Strr 31
EDL933 Strr Nalr Spontaneous Nalr 31
Derivatives of strain
MG1655 Strr
glgA glgA::cat This study
glgP glgP::cat This study
glgP malP glgP malP::cat This study
glgS glgS::cat This study
lamB lamB::cat This study
malEFG (malE-malG)::cat This study
malPQ (malP-malQ)::cat This study
malX malX::cat This study
Derivatives of strain
EDL933 Strr
glgA glgA::cat This study
glgP glgP::cat This study
glgP malP glgP malP::cat This study
glgS glgS::cat This study
lamB lamB::cat This study
malEFG (malE-malG)::cat This study
malEFG malX (malE-malG) malX::cat This study
malP malP::cat This study
malPQ (malP-malQ)::cat This study
malQ malQ::cat This study
malX malX::cat This study
ppsA pckA ppsA pckA::cat 31
Plasmids
pKD3 bla cat 11
pKD4 bla kan 11
pKD46 Ts Apr, ParaC--red
recombinase
11
pCP20 Ts Apr, FLP recombinase 11
pTag-mini-Tn5Km2 Apr Knr; mini-Tn5
transposon delivery
plasmid
22
a For simplicity, strains are named by strain and mutation(s).
b Nalr, nalidixic acid resistance; Apr, ampicillin resistance; Strr, streptomycin
resistance; Knr, kanamycin resistance; Ts, temperature-sensitive replication.
c E. coli Genetic Stock Culture Collection, Yale University.
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and nalidixic acid resistant (Strr Nalr) (31); Nalr was used to distinguish the
wild-type (reference strain) from the null allele mutants in fecal plate counts.
After the bacterial suspension was ingested, food and streptomycin-water (5
g/liter) were restored, and fecal plate counts were determined at 5 h, 24 h, and
on every other day thereafter for 15 days. Fecal samples were homogenized and
diluted in 1% tryptone broth and plated on MacConkey agar either containing
streptomycin (100 g/ml) and nalidixic acid (50 g/ml) to count the wild type or
containing streptomycin and kanamycin (40 g/ml) or chloramphenicol (30 g/
ml) to count the null allele mutants. Each colonization experiment was repeated,
on separate occasions, and averaged for six (or more) mice, such that the
presented values are the log10 mean number of CFU per gram of feces  the
standard error for each strain. In all experiments, a difference between two
strains of 10-fold CFU/g of feces was statistically significant, i.e., P  0.05 as
determined by the Student t test (two-tailed with unequal variance). The limit of
detection in fecal plate counts was 102 CFU/g of feces.
Signature-tagged mutagenesis. A signature-tagged mutant (STM) library of
E. coli EDL933 Strr ppsA pckA was constructed as previously described (43).
A total of 1,440 mutants were arrayed in 30 pools each containing 48 uniquely
tagged mutants with mini-Tn5Km2 insertions. The mutant library was
screened in streptomycin treated mice (as described above) in competition
with E. coli MG1655 Strr Nalr. Each pool of mutants was grown in Luria broth
supplemented with kanamycin in a microtiter plate at 37°C overnight. The
mutants from each microtiter plate were pooled, diluted, and mixed with a
10-fold-concentrated overnight culture of E. coli MG1655 Strr Nalr in 20%
sucrose to obtain an inoculum containing approximately 107 CFU of signa-
ture-tagged E. coli EDL933 Strr ppsA pckA mutants/ml and 1010 CFU of the
E. coli MG1655 Strr Nalr strain/ml. A 100-l portion of inoculum was fed to
two mice. Signature-tagged E. coli EDL933 Strr ppsA pckA mutants unable to
persist in the intestine 3 days after inoculation were identified by PCR and
hybridization analysis as previously described (43). The competition experi-
ment for colonization was repeated for selected mutants from the screening.
The locations of the mini-Tn5Km2 insertions were determined by DNA
sequence analysis, as described previously (3).
RESULTS
Colonization assays. Of the animal models available for
measuring the relative fitness of two bacterial strains for intes-
tinal colonization, the streptomycin-treated mouse is preferred
for the following reasons (for a review of intestinal coloniza-
tion models, see reference 3). Bioreactors (i.e., intestinal sim-
ulators) have proven useful for analyzing specific strain inter-
actions but, in addition to their failure to mimic intestinal
anatomy, it remains unclear what growth medium will dupli-
cate the complex nutritional makeup of the intestinal contents.
Conventional mice are resistant to experimental colonization.
The gnotobiotic mouse model is a powerful tool for comparing
a finite number of strains in direct competition, e.g., how two
strains adapt their substrate utilization in response to one
another but, in addition to being expensive and time-consum-
ing, this model lacks the diversity of background functions
provided by the “normal microbiota,” and gnotobiotic mice
exhibit physiological and anatomical differences from conven-
tional animals. Streptomycin treatment selectively removes
facultative anaerobes while leaving the anaerobic microbiota
essentially intact, i.e., at pretreatment population size; this
opens a previously unavailable niche, which can then be colo-
nized by experimentally introduced microorganisms such as E.
coli (23). In this model, streptomycin-treated mice are fed
streptomycin resistant strains of bacteria. Usually, these are
two isogenic strains that differ only in a single characteristic,
i.e., a mutant and its wild-type parent. If one of these strains
possesses even a slight advantage over the other, the conditions
of the mouse large intestine select for that strain and within a
few days, it becomes dominant. If neither strain possesses an
advantage, the two strains cocolonize and are maintained at
approximately equal levels. Since the population of a strain in
mouse feces is a reflection of its number in the mouse large
intestine, fecal counts are used to judge the relative colonizing
abilities of E. coli strains. The colonization data shown in Table
2 are given for day 1 (initiation) and day 15 (maintenance) for
mutations constructed in E. coli MG1655 and E. coli EDL933.
Growth from low to high numbers in the initiation stage likely
depends on utilization of nonlimiting nutrients made available
by removing the streptomycin-sensitive facultative anaerobes,
whereas persistence during the maintenance stage most likely
depends on competition for limiting nutrient(s) (7). Please
note that E. coli EDL933 does not cause disease in streptomy-
cin-treated CD-1 mice (45).
TABLE 2. Competitive colonization between maltose/glycogen mutants and wild-type E. coli strainsa
Respiratory enzyme Mutation
Avg (log10 CFU/g of feces)  SEM for:
E. coli EDL933 at: E. coli MG1655 at:
Day 1 Day 15 Day 1 Day 15
Maltose transport malEFG 0.4  0.1 3.3  0.2 0.0  0.1 0.4  0.3
Maltose PTS system malX 0.4  0.1 0.2  0.2 0.6  0.2 0.6  0.1
Maltose transport and PTS malEFG malX 0.2  0.1 2.3  0.2 0.6  0.2 2.2  0.2
Maltodextrin phosphorylase and
amylomaltase
malPQ 0.8  0.1 3.7  0.1 0.4  0.2 3.5  0.4
Maltodextrin phosphorylase malP 0.3  0.1 1.4  0.5b NDc ND
Amylomaltase malQ 0.3  0.1 3.3  0.4 ND ND
Maltoporin lamB 0.0  0.2 0.0  0.2 0.0  0.2 0.1  0.2
Glycogen phosphorylase glgP 0.3  0.1 2.4  0.2 0.5  0.2 3.2  0.1
Glycogen phosphorylase and maltodextrin
phosphorylase
glgP malP 0.3  0.2 2.5  0.2 0.4  0.1 2.5  0.2
Glycogen synthase glgA 0.2  0.1 2.3  0.2 0.2  0.1 2.9  0.2
Glycogen synthesis glgS 0.2  0.1 1.9  0.1 0.4  0.2 1.6  0.2
a Mice were fed 105 CFU each of a mutant and its wild-type parent. Mice were transferred to fresh cages every day, and feces samples no older than 24 h were assayed
every other day for 15 days. At each time point, for each mouse the log10 CFU/g of feces for the mutant was subtracted from the log10 CFU/g of feces for the wild type.
The average  the standard error of the mean of day 1 and day 15 data from six mice is shown. All values shown in boldface are statistically significant (P  0.005
Student t test	).
b P  0.08.
c ND, not determined.
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Evidence for in vivo glycogen and maltose metabolism by E.
coli EDL933. In colonizing the intestine, E. coli EDL933 grows
from low to high numbers and can do so in the presence of E.
coli MG1655 (31). To do this, it seems likely that E. coli
EDL933 uses nutrients that are not used by E. coli MG1655,
and we recently demonstrated significant differences in
monosaccharide utilization between the two strains during col-
onization of the mouse intestine (16). Previously, we showed
that genes involved in glycogen (glgS), maltose (malE), and
maltodextrin (lamB) catabolism were significantly induced in
E. coli MG1655 during growth on mucus, conditions that
mimic nutrient availability in the intestine (7). More recently,
we found that E. coli EDL933 induced malE and glgS during
growth on mucus (16). Lastly, an STM screen identified 14
mutants in an E. coli EDL933 ppsA pckA background that were
unable to colonize streptomycin treated mice in competition
with wild-type E. coli MG1655. The purpose for using the ppsA
pckA background was to avoid selection for genes involved in
gluconeogenesis (31). One of these insertions was in the malP
gene. The E. coli EDL933 ppsA pckA malP::miniTn5-Km2
STM mutant did not grow on maltose (data not shown), sug-
gesting a polar effect on the downstream malQ gene (5). Fur-
thermore, E. coli EDL933 ppsA pckA malP::miniTn5-Km2 had
a major colonization defect when competed in mice against its
E. coli EDL933 ppsA pckA parent (Fig. 1). Together, these
findings led us to consider the importance of maltose and
maltodextrin utilization for colonization of the intestine.
Maltose transport is important for intestinal colonization.
The importance of maltose utilization for colonization was
determined by testing maltose/maltodextrin ATP binding cas-
sette (ABC) transport system mutants for their ability to com-
pete with the wild-type in streptomycin-treated mice. Null mu-
tations were constructed that deleted the malEFG operon
encoding the maltose-binding protein and the two membrane-
spanning subunits of the maltose ABC transport system, with-
out impacting the adjacent malK-lamB-malM operon. malE,
malF, and malG mutants are reportedly unable to grow on
maltose or maltodextrin (46). Since mutants lacking the malt-
ose ABC transporter can grow on maltose when malX is ex-
pressed (39), we also made a malX-null allele strain, which
lacks a maltose phosphotransferase system, as well as a
malEFG malX double mutant. We verified the phenotypes of
these strains before proceeding with the colonization experi-
ments and found that mutation of malX had no effect, whereas
mutation of malEFG prevented growth on maltose and malt-
ose oxidation (Fig. 2). Mutation of malEFG significantly re-
duced but did not completely eliminate growth on maltodex-
trin (Fig. 2). We note that growth of a malEFG mutant on
maltodextrin has not been reported previously (5). Perhaps our
E. coli EDL933 malEFG strain grew poorly on maltodextrin by
partially degrading it to glucose in the periplasm by using the
MalS periplasmic amylase (19). We did not investigate the
maltodextrin phenotype of our malEFG mutant further but did
confirm the results of the transport mutant colonizations by
making independent mutations in the maltose and maltodex-
trin catabolic pathways, as described below. None of the mu-
tant strains used in the present study affected oxidation of any
other carbon sources by comparison to the wild-type on Biolog
GN2 plates (data not shown).
E. coli EDL933 malEFG was fed together with its wild-type
parent, each at 105 CFU/mouse. The mutant was able to ini-
tiate colonization and reached the same population size as the
wild-type on day 1 of the experiment but subsequently declined
steadily in numbers, reaching a 3.3-log difference by day 15
(Table 2 and Fig. 3A). E. coli EDL933 malX cocolonized with
the wild-type, indicating that the mutation did not cause a
colonization defect (Table 2 and Fig. 3B). The E. coli EDL933
malEFG malX strain behaved similarly to E. coli EDL933
malEFG in initiating colonization but subsequently declined in
numbers relative to the wild type and reached a 2.3-log differ-
ence by the conclusion of the experiment (Table 2 and Fig.
3C). E. coli MG1655 differed from E. coli EDL933 in having no
significant impact of the malEFG mutation on colonization
(Table 2). Likewise, E. coli MG1655 malX cocolonized with
wild-type E. coli MG1655. However, the E. coli MG1655
malEFG malX double mutant had a colonization defect similar
to that of E. coli EDL933 malEFG malX (Table 2). We con-
clude from these results that the transport of maltose and/or
maltodextrin is important for maintenance of intestinal colo-
nization. To distinguish the involvement of maltodextrin from
maltose transport, we knocked out LamB, encoded by lamB, a
maltodextrin-specific outer membrane porin; lamB mutants
grow on maltose but cannot grow on maltodextrins (44). This
phenotype was verified (Fig. 2). E. coli lamB mutants cocolo-
nized with their respective parent strains when fed together to
mice (Table 2 and Fig. 3D). From these results, we conclude
that the transport of maltose, but not maltodextrins, is impor-
tant for E. coli to colonize the murine intestinal tract.
Maltose catabolism is important for intestinal colonization.
Mutants lacking malP, which encodes maltodextrin phosphor-
ylase are unable to catabolize maltodextrin, and malQ mutants
are unable to catabolize maltose (5). To verify the result of the
mini-Tn5 insertion in malP (Fig. 1), we constructed malPQ-
null mutations in the E. coli EDL933 and E. coli MG1655
backgrounds; both of these malPQ mutants were unable to
maintain colonization during competition with their respective
wild types and had major colonization defects of 3.7 and 3.5
logs, respectively (Table 2 and Fig. 4A). The inability of E. coli
EDL933 malPQ to metabolize either maltose or maltodextrin
was confirmed (Fig. 2). It was reported that the growth of
malQ mutants is inhibited by maltose (5), which could nega-
tively impact competitive fitness in the intestine if maltose was
FIG. 1. E. coli EDL933 ppsA pckA malP::mini-Tn5-Km2 STM is
outcompeted by E. coli EDL933 ppsA pckA during colonization.
Strains were fed to mice at 105 CFU each.
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present. For this reason, we tested the mutant strains used here
for maltose and maltodextrin sensitivity; none of the strains
tested were sensitive to maltose or maltodextrin (Fig. 2). Since
the E. coli EDL933 malPQ population in the competitive col-
onization assay was only 1 log above the limit of detection (103
CFU/g of feces), we wanted to test whether the observed col-
onization defect resulted from an inability to grow in the in-
testine or an inability to compete with the wild type; the latter
was confirmed, since both malPQ mutant strains colonized at
wild-type levels when fed alone to mice (data not shown).
Thus, we conclude that the inability of the E. coli malPQ
mutants to catabolize maltose and/or maltodextrin strongly
and negatively impacted competitive fitness in the mouse in-
testine, which explains why the STM experiment revealed a
malP insertion mutant.
To distinguish the catabolism of maltose from that of malto-
dextrin, individual null mutations were constructed in malP
and malQ, which eliminated growth on maltodextrin and malt-
ose, respectively (5). Before proceeding with the colonizations,
we verified these phenotypes (Fig. 2). E. coli EDL933 malQ
was fed together with wild-type E. coli EDL933 and observed
to have a 3.3-log colonization defect (Table 2 and Fig. 4B),
confirming that maltose catabolism is important for coloniza-
tion. The malP mutation had a modest, but statistically insig-
nificant, impact on colonization of E. coli EDL933 (Table 2
and Fig. 4C). This result, together with the lack of a coloniza-
tion defect for the lamB mutant (Fig. 3C), suggests that mal-
todextrins are not important substrates in the intestine. These
results confirm the results obtained with the transporter mu-
tants, i.e., that the ability to use maltose, but not maltodextrins,
is important for intestinal colonization.
Maltose is necessary for E. coli EDL933 to initiate colonization
during competition with E. coli MG1655. To test whether mal-
tose metabolism is important for the pathogen E. coli EDL933
to compete with the commensal E. coli MG1655 in the mouse
intestine, 105 CFU of the E. coli EDL933 malQ mutant was fed
to mice together with 1010 CFU of wild-type E. coli MG1655.
The results show that E. coli EDL933 malQ was unable to
initiate in competition with wild-type E. coli MG1655 during
colonization, whereas the wild-type E. coli EDL933 initially
outcompetes E. coli MG1655 (compare Fig. 5A and Fig. 5B).
This result indicates that maltose is used by pathogenic E. coli
EDL933 to grow from low to high numbers while attempting to
gain residence in the mouse intestine when higher numbers of
commensal E. coli MG1655 are present.
FIG. 2. Phenotypes of E. coli EDL933 mutants used in the present study. Growth on maltose or maltodextrin as the sole carbon source was
determined in MOPS medium containing 0.2% carbohydrate. Maltose and maltodextrin sensitivity was determined in LB containing 0.2%
carbohydrate. The final OD600 values of cultures at 24 h are shown. Oxidation of maltose was determined on Biolog GN2 phenotype plates, as
shown in graphlets of relative amounts of substrate oxidized (y axis) versus time. Glycogen accumulation on LB agar containing 2% glucose was
visualized by staining with iodine vapor.
VOL. 76, 2008 IN VIVO MALTOSE AND GLYCOGEN METABOLISM 2535
 o
n
 O
ctober 23, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
Glycogen synthesis is important for colonization of the in-
testine. To test whether the ability to make glycogen (i.e., for
carbon storage) provides an advantage in the intestine, null
mutations were constructed in two of the genes that are nec-
essary for glycogen synthesis (glgA and glgS), the phenotypes of
which were previously described (21, 26). Mutation of glgA,
which encodes glycogen synthetase (26), resulted in a glyco-
gen-negative phenotype; mutation of glgS, which encodes a
factor that plays and important and yet unknown role in gly-
cogen synthesis (21), resulted in a reduced amount of glycogen;
neither mutation affected metabolism of maltose or maltodex-
FIG. 3. Maltose/maltodextrin transport mutants display colonization
defects. (A) E. coli EDL933 (malE-malG) has a colonization defect in
competition with E. coli EDL933 wild-type. (B) E. coli EDL933 malX
does not exhibit a colonization defect. (C) E. coli EDL933 malX
(malE-malG) has a colonization defect in competition with E. coli
EDL933 wild-type. (D) E. coli EDL933 lamB does not exhibit a colo-
nization defect. Strains were fed to mice at 105 CFU each.
FIG. 4. Catabolism of maltose but not maltodextrins is important
for competitive colonization of the mouse intestine. (A) E. coli
EDL933 (malP-malQ) has colonization defect in competition with E.
coli EDL933 wild-type. (B) E. coli EDL933 malQ has colonization
defect in competition with E. coli EDL933 wild-type. (C) E. coli
EDL933 malP does not exhibit a significant colonization defect.
Strains were fed to mice at 105 CFU each.
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trin (Fig. 2). E. coli EDL933 and E. coli MG1655 glgA mutants
had colonization defects of 2.3 and 2.9 logs, respectively, in
competition with their wild-type parents (Table 2 and Fig. 6).
Likewise, E. coli EDL933 and E. coli MG1655 glgS mutants
had colonization defects of 1.9 and 1.6 logs, respectively, in
competition with their wild-type parents (Table 2 and Fig. 6).
Thus, we conclude that that ability to synthesize carbon stores
in the form of glycogen is important for E. coli to colonize the
mouse intestine.
Glycogen degradation is important for colonization of the
intestine. We wanted to test whether the ability to degrade
glycogen provides a competitive advantage in the mouse intes-
tine. The primary pathway for glycogen degradation involves
glycogen phosphorylase, which is encoded by glgP. Although
the pathways for metabolism of glycogen and maltodextrin are
similar, they are not inextricable, i.e., although they have sim-
ilar -glucan phosphorylase activities, GlgP cannot replace
MalP in E. coli (5). Mutants were constructed in glgP, which
are unable to breakdown glycogen but could still catabolize
maltose and maltodextrin, as described previously (1). Before
proceeding with the colonization, we tested the phenotype and
found the E. coli EDL933 glgP strain was glycogen positive,
showed modestly reduced growth on maltodextrin compared
to the wild type, and metabolized maltose normally (Fig. 2). E.
coli EDL933 and E. coli MG1655 glgP mutants could initiate
but not maintain colonization, as indicated by 2.4- and 3.2-log
colonization defects, respectively, by day 15 postfeeding (Table
2 and Fig. 7). Apparently, MalP did not contribute to glycogen
degradation in vivo, since the malP mutation alone did not
significantly affect colonization and the glgP malP double mu-
tants had colonization defects of 2.5 logs at day 15, which were
similar to the colonization defects of the glgP mutants (Table
2). These results provide additional evidence that glycogen is
an important carbon store that provides a colonization advan-
tage in the intestine.
Evidence for a hunger or famine existence in the intestine.
Since glycogen is known to promote the survival of E. coli (42),
our finding that glycogen synthesis and degradation is neces-
sary for efficient colonization suggests that E. coli encounters
times of carbon limitation in the intestine that can be offset by
glycogen carbon stores. To confirm this possibility, we used a
strategy designed to provide the microbiota with a steady, high
level of a rapidly metabolized carbon source. We previously
showed that gluconate, which supports the growth of E. coli but
is not absorbed by the host, is able to affect the outcome of
experiments that depend on competition for gluconate (28).
We reasoned that the constant availability of an excess supply
of gluconate, provided by adding 2% gluconate to the drinking
water of mice throughout the experiment, would rescue the
dependence of colonized E. coli on stored glycogen. Indeed,
FIG. 5. Catabolism of maltose is necessary for E. coli EDL933 to compete efficiently with wild-type E. coli MG1655 in the mouse intestine.
(A) E. coli EDL933 wild-type (fed to mice at 105 CFU) initially out competes higher numbers of E. coli MG1655 wild-type (fed at 1010 CFU). (B) E.
coli EDL933 malQ (fed at 105 CFU) cannot compete with higher numbers of E. coli MG1655 wild-type (fed at 1010 CFU).
FIG. 6. Glycogen synthesis mutants do not compete effectively in the mouse intestine. (A) E. coli EDL933 glgA exhibits colonization defect
in competition with E. coli EDL933 wild-type. (B) E. coli EDL933 glgS exhibits colonization defect in competition with E. coli EDL933 wild-type.
Strains were fed to mice at 105 CFU each.
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the E. coli EDL933 and E. coli MG1655 glgP mutants were
equally fit for colonization in competition with their wild-type
parents when gluconate was supplied in the drinking water
(Fig. 7). Likewise, the addition of 2% gluconate to the drinking
water rescued the colonization defect of E. coli EDL933 glgA
(data not shown). These results support the conclusion that
glycogen is important for maintaining the highest possible en-
ergy levels during times of carbon limitation in the intestine.
DISCUSSION
In this study, we examined the metabolism of maltose, mal-
todextrin, and glycogen by pathogenic and commensal E. coli
in the mouse intestine. The results show that catabolism of the
disaccharide maltose provides a competitive advantage in vivo,
whereas degradation of exogenous forms of the more complex
glucose polymer, maltodextrin, does not. Furthermore, we
found that the utilization of maltose in vivo gives the pathogen
E. coli EDL933 a competitive advantage during the initiation
stage of colonization when competing with commensal E. coli
MG1655. The endogenous glucose polymer, glycogen, appears
to play a very important role in colonization. In support of the
hypothesis that E. coli relies on internal carbon stores to main-
tain colonization during periods of famine, we found that by
providing a constant supply of a readily metabolized sugar, i.e.,
gluconate, in the drinking water, the competitive disadvantage
of E. coli glycogen metabolism mutants (e.g., glgP) was res-
cued.
The hypothesis that glycogen provides a source of internal
carbon and energy storage and thus is advantageous for animal
colonization and virulence was considered previously. How-
ever, the results from the two published studies are in conflict
and neither provided a direct test of the hypothesis. Bonafonte
et al. (4) showed a correlation between the amount of glycogen
stores in Salmonella enterica serovar Enteritidis and the 50%
lethal dose in 1-day-old chicks. In that study, there was no way
to know whether the stored glycogen was used by the bacteria
during the course of infection. In another study, McMeechan
et al. (30) focused on the role of ADP-glucose pyrophosphor-
ylase, encoded by glgC, in Salmonella enterica serovar Typhi-
murium. These authors found no significant differences in in-
testinal colonization or virulence (in 1-day-old chicks) between
strains carrying glgC mutations or wild-type alleles in three
different serovars (Gallinarum, Pullorum, or Typhimurium)
(30). The glgC strains were thought not to accumulate glycogen
because they cannot make the glycogen precursor, ADP-glu-
cose. However, that conclusion is brought into question by the
recent finding that glgC mutants of E. coli and S. enterica
serovar Typhimurium possess an alternative pathway for ADP
glucose formation and can accumulate glycogen under certain
conditions (33).
The experiments described here directly tested the hypoth-
esis that synthesis and utilization of glycogen is necessary for
efficient colonization of the intestine by E. coli. Mutants lack-
ing GlgA, which cannot synthesize glycogen, had significant
colonization defects in competition with the wild-type strain
that accumulates glycogen normally. Likewise, mutants lacking
GlgP, which cannot degrade glycogen, had similarly significant
FIG. 7. Colonization defects of glycogen degradation mutants are rescued by adding 2% gluconate to drinking water of mice. (A) E. coli
EDL933 glgP and (C) E. coli MG1655 glgP exhibit colonization defects in competition with their respective wild-type parents. (B and D) These
colonization defects are rescued by addition of gluconate to the drinking water . Strains were fed to mice at 105 CFU each.
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colonization defects. Loss of GlgS, which is known to impair
glycogen metabolism, resulted in a colonization defect similar
to those of mutants lacking GlgA or GlgP. These data provide
strong evidence in support of the hypothesis that glycogen
metabolism is important in colonized E. coli. The need for
glycogen stores may reflect a physiological status of nutrient
limitation in the intestine. Accordingly, glycogen stores might
be consumed by colonized bacteria as they cometabolize mix-
tures of severely limiting carbon sources or switch from one
substrate to another. Alternatively, carbon availability in the
intestine might be intermittent, requiring the cell to obtain
maintenance energy from glycogen during brief periods of
famine. If it is true that glycogen provides a source of carbon
and energy during times of nutrient limitation, we reasoned
that by providing a constant source of a readily metabolized
carbon source the colonization defect of a glgP mutant would
be rescued. We previously established that gluconate, which is
not absorbed in the mammalian gastrointestinal tract, is avail-
able to strains that can use it and can impact colonization,
strongly suggesting that gluconate provided in the drinking
water of mice is metabolized by E. coli in the intestine (28).
Indeed, we found that addition of gluconate to the drinking
water made glgP mutants better colonizers, equal to wild-type
E. coli (Fig. 7). These results indicate that glycogen stores not
only support the long-term survival of E. coli outside of the
host (42) but also enhance persistence in the intestine.
The biochemistry of glycogen metabolism is ideally suited to
provide energy during brief respites from exogenous carbon
and energy sources. The genes for glycogen synthesis and deg-
radation are arranged together in an operon and are coregu-
lated, such that the enzymes of both glycogen synthesis and
degradation are coexpressed (37). At first, this may seem par-
adoxical but, in fact, since both sets of enzymes are present, the
cell is poised at any given moment to either make glycogen or
degrade it, as conditions allow. Recall that glycogen is formed
when carbon is in excess but some other nutrient is limiting and
glycogen is degraded when carbon is limiting (13, 36). More-
over, glycogen is synthesized from glucose-1-phosphate, which
is also the breakdown product of glycogen. Since the enzymes
of glycogen synthesis and degradation are coexpressed, their
activities (i.e., accumulation or catabolism of glycogen) are
reciprocally controlled by the physiological constraints of car-
bon source excess and depletion, both of which are reflected in
the intracellular pool of glucose-1-phosphate, which in turn
reflects the energy status of the cell (5). If nutrient limitation
prevails in the intestine and if this limitation includes, period-
ically, nutrients other than carbon sources (i.e., nitrogen), then
the biochemical regulation of glycogen metabolism is ideal for
responding to the instantaneous excesses and limitations of
carbon sources and other nutrients. Perhaps the reason that
glycogen storage is widespread in enteric bacteria is because
this is a necessary strategy for rapid growth in the intestine,
where there is intense competition for resources.
While E. coli apparently depends on endogenous stores of
the polysaccharide, glycogen, it cannot metabolize exogenous
polysaccharides, with the exception of maltodextrin (29). The
data presented here indicate that maltodextrin does not sup-
port colonization. Thus, the in vivo catabolic capacity of E. coli
must be limited primarily to mono- and disaccharides. Previous
in vivo studies of E. coli catabolism focused on monosaccha-
rides (7). We have, however, now studied a few disaccharides
and found that lactose does not support colonization by E. coli
EDL933 and E. coli MG1655 (16), nor do 
-glucuronides sup-
port colonization by E. coli MG1655 (7). The in vivo catabo-
lism of -glycosides, i.e., trehalose and sucrose, and -galac-
tosides, i.e., melibiose, has not been studied and should be, but
at least one disaccharide, maltose, supports colonization by E.
coli EDL933 and E. coli MG1655.
Clearly, growth on intestinal polysaccharides is the domain
of the anaerobes that secrete polysaccharide hydrolyzing en-
zymes (10, 15, 41). Some, if not all, dominant intestinal anaer-
obes preferentially utilize oligosaccharides over mono- and
disaccharides (2). Moreover, at least some minor members of
the intestinal microbiota grow by cross-feeding on sugars re-
leased by the polysaccharide degraders (17, 40). For example,
there is recent evidence that vancomycin-resistant Enterococ-
cus colonizes the intestine by growing on monosaccharides
released by breakdown of complex polysaccharides by the in-
digenous microbiota (38). As we suggested previously (7) and
in accordance with the findings summarized here, E. coli al-
most certainly colonizes the intestine by cross-feeding on sim-
ple sugars provided by anaerobic polysaccharide degradation.
These sugars must be of limited availability, since E. coli relies
on endogenous carbon stores to efficiently colonize the intes-
tine. Therefore, changes in the microbiota and/or polysaccha-
ride availability that further limit the availability of the nutri-
ents preferred by E. coli would limit its colonization.
Importantly, we take this to mean that there is merit to com-
bating enteric infections by using probiotics or prebiotics (20)
to manipulate the intestinal microbiota in such a way as to limit
the availability of sugars preferred by E. coli O157:H7 (16) and
perhaps other pathogens. Accordingly, prebiotics would have
to stimulate populations that consume the sugars favored by
invading pathogens, while probiotics could accomplish this
directly, since organisms could be engineered to specifically
consume preferred nutrients.
Studies of the physiology of carbohydrate metabolism and its
contribution to pathogenesis are yielding novel, broadly appli-
cable insights into host-pathogen interactions, which are spe-
cifically related to the underlying mechanisms that enable
pathogens to successfully colonize their hosts. Many of the
nutrient acquisition systems used by E. coli are similar to those
used by other mucosal pathogens. Therefore, such studies will
aid in finding new and effective treatments. In conclusion, we
wish to emphasize that therapies designed to specifically re-
duce intestinal nutrient availability may be effective because
organisms such as E. coli O157:H7 live a hunger or famine
existence, as indicated by their requirement for glycogen
stores, which places the pathogens in peril of starvation before
infection can begin, if administration of prebiotics or probiotics
depletes their preferred nutrients.
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